Omeros (OMER) Earnings Analysis
Omeros (OMER) next reports earnings on 2026-08-13, consensus EPS -0.27 USD. Last quarter (2026-03-31) it beat with EPS 3.14 USD vs -0.55 USD est (+670.9%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 7.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OMER next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.27 USD |
| Revenue estimate | 0.01B |
OMER earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-31 | 3.14 USD | -0.55 USD | +670.9% | Beat |
| 2025-11-13 | -0.19 USD | -0.58 USD | +67.2% | Beat |
| 2025-08-14 | -0.53 USD | -0.55 USD | +3.6% | Beat |
| 2025-05-15 | -0.65 USD | -0.57 USD | -14% | Miss |
| 2025-03-31 | -0.63 USD | -0.78 USD | +19.2% | Beat |
| 2024-11-13 | -0.64 USD | -0.7 USD | +8.6% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
OMER valuation and analyst view
| Trailing P/E | 7.57 |
|---|---|
| Trailing EPS | 1.198 USD |
| Price / book | -11.17 |
| Dividend yield | 0.00% |
| Market cap | 0.70B |
| Analyst consensus | Buy (11 buy / 6 hold / 2 sell) |
| Avg price target | 33 USD |
Related research pages
Frequently asked questions
When is Omeros (OMER)'s next earnings date?
Omeros is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.27 USD and revenue estimate of 0.01B.
Did OMER beat earnings last quarter?
In its 2026-03-31 report, OMER posted EPS of 3.14 USD versus a -0.55 USD estimate — a beat of 670.9%.
What is OMER's earnings track record?
Over the last 6 reported quarters with consensus data, OMER beat estimates 5 times (83%).
What is OMER's current P/E ratio and EPS?
OMER trades at a trailing P/E of 7.57 on trailing EPS of 1.198183799754106 USD.
What do analysts rate OMER?
Analyst consensus is "Buy" across 19 ratings (1 strong buy, 10 buy, 6 hold, 2 sell, 0 strong sell). Average 12-month price target: 33 USD.